Samsung's Lee fined over illegally using propofol

·1 min read
South Korea Samsung (ASSOCIATED PRESS)
South Korea Samsung (ASSOCIATED PRESS)

Samsung’s de facto chief Lee Jae-yong was fined 70 million won (about $60,000) on Tuesday for illegally using the anesthetic drug propofol, about two months after he was released on parole over a separate corruption case.

The Seoul Central District Court said it convicted Lee, vice chairman of Samsung Electronics, of violating a law on drug controls. It said Lee was also ordered to forfeit about 10 million won ($8,570).

Lee, who is the third-generation heir of South Korea's biggest company, Samsung, has been involved in a series of corruption cases lately. The company's crown jewel, Samsung Electronics, singlehandedly represents about 20% of South Korea’s entire stock market value and one-fourth of its total exports.

Prosecutors earlier accused Lee of taking propofol at a hospital in Seoul about 40 times for non-medical purposes. Lee’s lawyers said he took propofol in line with a doctor’s prescription, according to the court.

Propofol is used for anesthesia and sedation. Its use gained notoriety in 2009 when pop star Michael Jackson died of a propofol overdose.

In August, Lee was released from prison after serving 18 months of a 30-month sentence for embezzling millions of dollars from corporate funds to bribe then-President Park Geun-hye The bribery scheme was to ensure Geun-hye's support for a 2015 merger between two Samsung affiliates that tightened Lee's control over the corporate empire.

Lee is also facing a separate court trial over alleged stock price manipulation, auditing violations and other financial crimes related to the 2015 merger.

Read More

UK government must make people fly less, say climate advisers

Minister can’t rule out below-inflation pay rise – live Budget updates

South African court rules Zuma's corruption case to continue

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting